Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.4711
+0.0039 (0.83%)
At close: Oct 2, 2026, 4:00 PM EDT
0.4755
+0.0044 (0.93%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $3.57 million as of October 2, 2026. Its market cap has decreased by -68.69% in one year.
Market Cap
3.57M
Enterprise Value
-11.58M
1-Year Change
-68.69%
Ranking
Category
Stock Price
$0.47
ChartMarket Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $3.57M, a decrease of -98.61%. That is a compound annual growth rate of -37.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 3.60M | -50.00% |
| Dec 31, 2025 | 7.20M | -15.29% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
| Aug 22, 2017 | 257.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaCyte Biotech | 4.30M |
| GRI Bio | 4.28M |
| Calidi Biotherapeutics | 3.99M |
| Jupiter Neurosciences | 3.36M |
| Cadrenal Therapeutics | 3.35M |
| Propanc Biopharma | 3.21M |
| Addex Therapeutics | 3.19M |
| Aptevo Therapeutics | 3.17M |